Literature DB >> 10974535

Novel nucleolar protein, midnolin, is expressed in the mesencephalon during mouse development.

M Tsukahara1, H Suemori, S Noguchi, Z S Ji, H Tsunoo.   

Abstract

Using the gene trap method and the selection of embryonic stem cells in vitro, we have identified several novel genes involved in mouse development. The detailed analysis of one of these, named midnolin (midbrain nucleolar protein), is reported here. Expression of the midnolin gene is developmentally regulated: it is strongly expressed at the mesencephalon (midbrain) of the embryo in day 12.5 (E12.5) mice. The midnolin encodes a protein of 508 amino acids (aa), which contains a Ubiquitin-like domain. The intracellular distribution of the midnolin was studied by using midnolin-green fluorescent protein (GFP) fusion proteins. Midnolin was found to be localized in the nucleus and nucleolus, but not in the cytoplasm. The nucleolar localization signal was determined to be a 28aa peptide (440-QQKRLRRKARRDARGPYHWTPSRKAGRS-467) located at the C-terminal region of the midnolin. Our results suggest that midnolin is involved in regulation of genes related to neurogenesis in the nucleolus.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10974535     DOI: 10.1016/s0378-1119(00)00259-6

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  12 in total

1.  Breakpoint determination of 15 large deletions in Peutz-Jeghers subjects.

Authors:  Nicoletta Resta; Roberto Giorda; Rosanna Bagnulo; Silvana Beri; Erika Della Mina; Alessandro Stella; Marilidia Piglionica; Francesco Claudio Susca; Ginevra Guanti; Orsetta Zuffardi; Roberto Ciccone
Journal:  Hum Genet       Date:  2010-07-11       Impact factor: 4.132

2.  Genome-wide methylomic and transcriptomic analyses identify subtype-specific epigenetic signatures commonly dysregulated in glioma stem cells and glioblastoma.

Authors:  Rajendra P Pangeni; Zhou Zhang; Angel A Alvarez; Xuechao Wan; Namratha Sastry; Songjian Lu; Taiping Shi; Tianzhi Huang; Charles X Lei; C David James; John A Kessler; Cameron W Brennan; Ichiro Nakano; Xinghua Lu; Bo Hu; Wei Zhang; Shi-Yuan Cheng
Journal:  Epigenetics       Date:  2018-08-06       Impact factor: 4.528

3.  Separating the contribution of glucocorticoids and wakefulness to the molecular and electrophysiological correlates of sleep homeostasis.

Authors:  Valérie Mongrain; Susana A Hernandez; Sylvain Pradervand; Stéphane Dorsaz; Thomas Curie; Grace Hagiwara; Phung Gip; H Craig Heller; Paul Franken
Journal:  Sleep       Date:  2010-09       Impact factor: 5.849

4.  Identification of the ubiquitin-like domain of midnolin as a new glucokinase interaction partner.

Authors:  Anke Hofmeister-Brix; Katrin Kollmann; Sara Langer; Julia Schultz; Sigurd Lenzen; Simone Baltrusch
Journal:  J Biol Chem       Date:  2013-11-01       Impact factor: 5.157

5.  Whole exome sequencing in females with autism implicates novel and candidate genes.

Authors:  Merlin G Butler; Syed K Rafi; Waheeda Hossain; Dietrich A Stephan; Ann M Manzardo
Journal:  Int J Mol Sci       Date:  2015-01-07       Impact factor: 5.923

6.  Clinical and molecular characterization of a de novo 19p13.3 microdeletion.

Authors:  Pietro Palumbo; Orazio Palumbo; Maria Pia Leone; Raffaella Stallone; Teresa Palladino; Leopoldo Zelante; Massimo Carella
Journal:  Mol Cytogenet       Date:  2016-05-27       Impact factor: 2.009

7.  Molecular alterations in skeletal muscle in rheumatoid arthritis are related to disease activity, physical inactivity, and disability.

Authors:  Kim M Huffman; Ryan Jessee; Brian Andonian; Brittany N Davis; Rachel Narowski; Janet L Huebner; Virginia B Kraus; Julie McCracken; Brian F Gilmore; K Noelle Tune; Milton Campbell; Timothy R Koves; Deborah M Muoio; Monica J Hubal; William E Kraus
Journal:  Arthritis Res Ther       Date:  2017-01-23       Impact factor: 5.156

8.  Tracing the dynamics of gene transcripts after organismal death.

Authors:  Alex E Pozhitkov; Rafik Neme; Tomislav Domazet-Lošo; Brian G Leroux; Shivani Soni; Diethard Tautz; Peter A Noble
Journal:  Open Biol       Date:  2017-01       Impact factor: 6.411

9.  Midnolin is a novel regulator of parkin expression and is associated with Parkinson's Disease.

Authors:  Yutaro Obara; Toru Imai; Hidenori Sato; Yuji Takeda; Takeo Kato; Kuniaki Ishii
Journal:  Sci Rep       Date:  2017-07-19       Impact factor: 4.379

10.  Midnolin is a confirmed genetic risk factor for Parkinson's disease.

Authors:  Yutaro Obara; Hidenori Sato; Takahiro Nakayama; Takeo Kato; Kuniaki Ishii
Journal:  Ann Clin Transl Neurol       Date:  2019-10-06       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.